Kineta

Developing immune-modulating therapeutics and vaccine adjuvants for autoimmune and infectious diseases

placeSeattle, Washington, United States calendar_todayFounded 2008 groups12 employees language kinetabio.com

Registered entities

Innovation

38 patent families (13 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing, Mechanical engineering; filing pace accelerating. Cited 1,897 times.

YearFilings
201510
201612
20175
20182
20192
20204
20212
20221
202311
202411
20257
20262

Investor mix

12 investors on record; lead investors include Cheongbo Industrial.

Investor typeCountShare
Venture capital325%
Angel & family office217%
Other / undisclosed758%
Coming soon